However, LDHB was found to be overexpressed in triple-negative breast cancer cell lines and was correlated with poor prognosis among breast cancer patients [15]; it was also found to be overexpressed in highly glycolytic, mesenchymal breast cancer cell lines [26]. The gene discussed is LDHB; the disease is breast carcinoma.